Introduction {#s1}
============

Sepsis remains a challenge to the healthcare system and is associated with frequent hospitalizations and high mortality \[[@R01]\]. The pathophysiology of sepsis has been intensively studied \[[@R02], [@R04]\]. However, clinical studies of sepsis are often hindered by its heterogeneous time course \[[@R04], [@R05]\]. Sepsis treatment studies have emphasized early recognition and treatment is critical to successful outcomes \[[@R06]\]. The effectiveness of interventions, such as fluid or antibiotic administration, is time-dependent \[[@R07]\]. The patient with sepsis who presents with hypotension is intuitively a different clinical phenotype than the patient who presents over a more prolonged time course \[[@R08], [@R10]\]. This distinction may be important in terms of prognosis and may influence the interventions deployed. We examined these two phenotypes of septic shock presentation within the first day of hospital admission and their response to standard of care (SOC).

We performed a retrospective review of patients presenting with sepsis, severe sepsis, and septic shock. We compared patients who presented with initial hemodynamic stability before evolving into septic shock to those who presented initially with septic shock in terms of initial findings, management, and outcomes. We investigated the associated patient-specific and treatment factors involved with the evolution of severe sepsis to septic shock. Early recognition of patients with severe sepsis who are at risk for deterioration into septic shock could potentially be useful in management decisions.

Materials and Methods {#s2}
=====================

Study design and population {#s2a}
---------------------------

We conducted a retrospective cohort study at the Veterans Affairs (VA) New York Harbor Healthcare System, an urban tertiary referral center. Data were from the electronic medical record (EMR) of all patients that were identified as having been admitted with the diagnosis of sepsis, severe sepsis, or septic shock in 2011 and 2012, (n = 542, [Fig. 1](#F1){ref-type="fig"}). We excluded patients who 1) remained stable and had normotensive blood pressure during the initial 24 h of their hospitalization, 2) became hypotensive from etiologies other than sepsis or 3) had received significant sepsis treatment, specifically fluids or antibiotics, prior to hospital admission from other hospitals/nursing facilities and 4) did not have complete blood pressure data available. Study was approved by the hospital's Institutional Review Board and granted a waiver of informed consent.

![Retrospective cohort study design. H: hours; IH: initially hypotensive; INT: initially normotensive; OSH: outside hospital; SBP: systolic blood pressure; MAP: mean arterial pressure.](jocmr-08-575-g001){#F1}

The remaining septic patients were identified as either cases of initial hypotension (IH) or initial normotension (INT). Patients with IH had systolic blood pressure (SBP) ≤ 90 mm Hg or mean arterial pressure (MAP) ≤ 65 mm Hg at the time of presentation. INT subjects presented with SBP \> 90 mm Hg or MAP \> 65 mm Hg but then developed hypotension in the first 24 h after hospitalization as defined by IH blood pressure parameters, or had a decrease in SBP more than 40 mm Hg from baseline, as consistent with Society of Critical Care Medicine/American College of Chest Physicians criteria for septic shock \[[@R01], [@R13]\].

We collected demographic data, chronic comorbidities, home medications, reason for hospital admission, length of stay, survival, laboratory data, and timing of sepsis treatment from their EMR. Respiratory failure was defined as requiring ventilator use; kidney failure was defined by a creatinine increase 1.5-fold from baseline; liver failure was defined by a bilirubin level greater than 1.2 mg/dL.

Statistical analysis {#s2b}
--------------------

SPSS 21 (IBM, Armonk, NY) was used for database management and statistics. Data were analyzed by Student's *t*-test and Pearson Chi-square test where appropriate. A two-sided P-value less than 0.05 was considered significant. We used logistic regression to examine clinical biomarkers that were predictive of the dichotomous outcome of being INT or IH. Variables identified as potential confounders and those with a P-value ≤ 0.05 in univariate analysis were included in the multivariate logistic regression model. Over-fitting was limited by excluding variables with inadequate prevalence and assessed by the Hosmer-Lemeshow goodness-of-fit. The model discrimination was evaluated using the receiver operating characteristic area under the curve (ROC-AUC).

Results {#s3}
=======

Demographic characteristics of cohort {#s3a}
-------------------------------------

Retrospective case cohort design of patients with sepsis in 2011 - 2012 based on inclusion/exclusion criteria is shown in [Figure 1](#F1){ref-type="fig"}. Among a total of 542 patients who were admitted for sepsis, we identified 52 (9.6%) patients with IH and 62 (11.4%) patients with INT. Demographics of the INT and IH groups are described in [Table 1](#T1){ref-type="table"}.

###### Demographics

                                            IH         INT       P^‡^
  ----------------------------------------- ---------- --------- -------
  Number of subjects                        52         62        
  Age, years\*                              79 (12)    75 (11)   0.124
  Gender, male^†^                           52 (100)   61 (98)   0.362
  Race^†^                                                        0.013
    Caucasian                               27 (52)    46 (74)   
    African American and other              25 (48)    16 (26)   
  Outpatient setting^†^                                          0.619
    Home                                    36 (69)    44 (71)   
    Nursing Home                            16 (31)    17 (27)   
    Undomiciled                             0 (0)      1 (2)     
  Days of illness prior to presentation\*   3 (3)      3 (3)     0.207
  BMI, kg/m^2^\*                            24 (5)     27 (6)    0.010

BMI: body mass index. \*Value expressed as mean (SD). ^†^Value expressed as N (%). ^‡^Significance assessed by Student's *t*-test or Pearson's Chi-square test as applicable.

The two groups were not significantly different in age, gender, days of illness prior to presentation, or pre-hospitalization setting. They were significantly different in regards to race and BMI. INT patients were more likely to be Caucasian and had higher BMI. INT patients were also more likely to be on alpha-blockers and chronic steroids. They were also not significantly different in comorbidities, or most home medications ([Table 2](#T2){ref-type="table"}).

###### Past Medical History

                             IH        INT       P^†^
  -------------------------- --------- --------- -------
  Comorbid conditions\*                          
    Cancer                   18 (35)   21 (34)   0.933
    DM                       16 (31)   24 (39)   0.376
    ESRD                     11 (21)   6 (10)    0.087
    Heart disease            22 (42)   31 (50)   0.412
    Neurologic disease       11 (21)   15 (24)   0.700
  Home medications\*                             
    ACE/ARB                  22 (42)   27 (44)   0.834
    α-blocker                12 (23)   25 (40)   0.050
    Aspirin                  20 (39)   28 (45)   0.525
    β-blocker                26 (50)   25 (40)   0.301
    Ca^2+^ channel blocker   12 (23)   13 (21)   0.786
    Chronic Steroid          3 (6)     11 (18)   0.045
    Diuretics                20 (39)   20 (32)   0.489
    Statin                   18 (35)   28 (45)   0.253

DM: diabetes mellitus; ESRD: end-stage renal disease; ACE/ARB: angiotensin converting enzyme inhibitor/angiotensin receptor blocker. Heart disease: coronary artery disease, congestive heart failure, and arrhythmia; neurologic disease: dementia, Parkinson's disease, seizure, cerebral vascular aneurysm, and multiple sclerosis. \*Value expressed as N (%). ^†^Significance assessed by Pearson's Chi-square test.

Clinical presentation and source of infection {#s3b}
---------------------------------------------

At presentation, mean heart rate and temperature were significantly higher in the INT group ([Table 3](#T3){ref-type="table"}).

###### Clinical Parameters at Presentation

                                     IH          INT         P\*
  ---------------------------------- ----------- ----------- ----------
  HR, per minute                     81 (22)     97 (25)     0.001
  RR, per minute                     20 (4)      20 (5)      0.275
  BP, mm Hg                                                  
    Systolic                         81 (10)     120 (16)    \< 0.001
    Diastolic                        46 (9)      71 (14)     \< 0.001
    MAP                              57 (7)      88 (12)     \< 0.001
  Temperature, °F                    98.8 (2)    100.4 (2)   \< 0.001
  APACHE II lab values within 24 h                           
    CBC                                                      
      WBC, × 10^3^/µL                17 (10)     14 (8)      0.054
      Hct, %                         33 (6)      34 (7)      0.470
      Platelet, × 10^3^/µL           230 (140)   211 (92)    0.383
    Chemistries                                              
      Sodium, mEq/L                  141 (7)     139 (5)     0.057
      Potassium, mEq/L               5.7 (6)     4.7 (0.9)   178
      CO~2~, mmol/L                  22 (7)      25 (6)      0.037
      Creatinine, mg/dL              3.9 (3)     2.2 (1)     \< 0.001
    Liver function test                                      
      AST, U/L                       117 (320)   93 (190)    0.616
      ALT, U/L                       107 (321)   63 (127)    0.327
      Bilirubin, mg/dL               1.6 (4.2)   1.0 (0.8)   0.215
      Lactate, mmol/L                3 (3)       3 (2)       0.476

HR: heart rate; RR: respiration rate; BP: blood pressure; MAP: mean arterial pressure; CBC: complete blood count; WBC: white blood count; Hct: hematocrit; AST: aspartate transaminase; ALT: alanine transaminase. All available values reported in mean (SD). \*Calculated by Student's *t*-test.

The average blood pressure of the IH group was significantly lower (81/46, MAP: 57 mm Hg), compared to the INT group (121/71, MAP: 88 mm Hg). Over the next 24 h, laboratory values were obtained and the most abnormal values were recorded ([Table 3](#T3){ref-type="table"}). Patients in IH and INT groups had similar white blood cell counts, hemodynamic stability, and serum sodium values. The IH group had significantly higher levels of serum creatinine compared to INT, but this may be a reflection of the higher prevalence of end-stage renal disease (ESRD) in the IH group compared to INT ([Table 2](#T2){ref-type="table"}) as incidence of acute renal failure was not different. Mean bicarbonate serum level was also higher in INT patients, although both expressed average levels within the normal range ([Table 3](#T3){ref-type="table"}). The INT patients were also more likely to be septic from pneumonia compared to other sources of infection, whereas IH patients more likely had positive, gram positive cultures from specimens other than blood or urine ([Table 4](#T4){ref-type="table"}).

###### Sepsis Source and Treatment

                                 IH            INT           P^‡^
  ------------------------------ ------------- ------------- -------
  Source of infection^†^                                     
    Cellulitis                   3 (6)         9 (15)        0.130
    GI                           12 (23)       9 (15)        0.240
    Line infection               3 (6)         1 (2)         0.230
    Pneumonia                    5 (10)        15 (24)       0.042
    Urinary tract                25 (48)       22 (36)       0.174
    Unclear source               6 (12)        7 (11)        0.967
  Positive culture^†^                                        
    Blood                        12 (23)       16 (26)       0.736
    Urine                        19 (37)       17 (27)       0.297
    Others                       14 (27)       4 (7)         0.003
  Gram stain^†^                                              
    Gram positive                18 (35)       9 (15)        0.012
    Gram negative                23 (44)       21 (34)       0.258
  Time to hypotension, H:min\*   \-            3:18          \-
  Time to antibiotics, H:min\*   2:21 (1:48)   2:52 (2:47)   0.268
  Amount of fluid in 24 h, L\*   3.9 (2)       4.3 (2)       0.217
  Required vasopressor^†^        12 (23)       13 (21)       0.786
  Mortality^†^                                               
    28 days                      14 (27)       15 (24)       0.739
    1 year                       28 (54)       31 (50)       0.682

GI: gastrointestinal; H: hours; min: minutes. \*Value expressed as mean (SD). ^†^Value expressed as N (%). ^‡^Significance assessed by Student's *t*-test or Chi-square test as applicable.

Treatment and measures of outcome {#s3c}
---------------------------------

INT and IH groups did not differ in treatment protocols for their sepsis ([Table 4](#T4){ref-type="table"}). Of interest, both groups received antibiotics within 3 h, but INT patients developed hypotension to an average of 79/48 mm Hg (MAP: 59 mm Hg) at 3 h and 18 min. INT and IH patients also received similar fluid volumes over the first 24 h, and had similar vasopressor and ventilator requirements. Other measures of the severity of illness were studied in the population ([Table 5](#T5){ref-type="table"}). The INT and IH groups had similar end-organ dysfunction, length of stay, and mortality at 28 days or 1 year. INT patients had a mean APACHE II score of 18, compared to IH patients with mean 20 (P = 0.07).

###### Indices of Severity of Illness

  ----------------------------------------------------------
                                 IH        INT       P^‡^
  ------------------------------ --------- --------- -------
  Charlson comorbidity index\*   7 (2)     7 (2)     0.795

  APACHE II\*                    20 (5)    18 (5)    0.070

  Organ dysfunction^†^                               

    Respiratory                  7 (14)    8 (13)    0.930

    Kidney                       35 (67)   38 (61)   0.505

    Liver                        11 (22)   19 (31)   0.277

  Length of stay, days\*                             

    ICU\                         15 (13)   17 (26)   0.149

    Hospital                     8 (6)     8 (6)     0.960
  ----------------------------------------------------------

\*Value expressed as mean (SD). ^†^Value expressed as N (%). ^‡^Significance assessed by Student's *t*-test or Chi-square test as applicable.

Association between development of INT and clinical biomarkers {#s3d}
--------------------------------------------------------------

A logistic regression model to predict INT was created and adjusted for race, source of infection, BMI, and age ([Table 6](#T6){ref-type="table"}). Source of sepsis was coded as a dichotomous variable of pneumonia versus other sources to prevent over-fitting. Potential biomarkers were individually tested as crude variables for ability to predict INT as an outcome, and then incorporated into a final multivariable model in stepwise regression.

###### Logistic Regression Model Predictive of INT

  Covariates    Crude\*                P       Adjusted\*              P
  ------------- ---------------------- ------- ----------------------- -------
  α-Blocker     2.25 (0.991 - 5.118)   0.053   3.02 (1.09 - 8.36)      0.033
  Caucasian     2.66 (1.21 - 5.85)     0.015   3.23 (1.23 - 8.50)      0.018
  Temperature   1.37 (1.15 - 1.64)     0.001   1.36 (1.11 - 1.67)      0.003
  Age           0.98 (0.94 - 1.01)     0.124   0.97 (0.93 - 1.01)      0.188
  BMI           1.09 (1.02 - 1.17)     0.014   1.08 (0.99 - 1.17)      0.071
  Pneumonia     2.74 (0.92 - 8.22)     0.072   2.70 (0.80 - 9.15)      0.110
  AUC                                          0.815 (0.736 - 0.894)   

AUC: area under the curve. \*Values expressed as odds ratio (95% CI). Hosmer-Lemeshow of adjusted final model: Chi-square 9.67, df = 8, P = 0.289.

Outpatient alpha-blocker use was very predictive of being in the INT group and increased odds 302% ([Table 6](#T6){ref-type="table"}). An increase of 1 °F in temperature increased odds by 36% of being in the INT group. Of interest, race was also a significant predictor of INT. Caucasians were 323% more likely of presenting in the INT group. ROC curve analysis had AUC of 0.815 (95% CI: 0.736 - 0.894) and demonstrated good predictive ability (Supplementary Fig. 1, www.jocmr.org). The final model was robust and did not suffer from over-fitting, with Hosmer-Lemeshow Chi-square of 9.67 (P = 0.289). Sensitivity of the model was 75.0%, and specificity was 77.4%.

Discussion {#s4}
==========

The major findings of our retrospective study include that the presentation of INT is at least as common as IH subgroup. The INT patients differed from the IH patients in that they had increased sympathetic-adrenergic tone manifested by higher heart rate and body temperature, higher BMI, race, higher rate of pneumonia as the source of sepsis, and more frequent alpha-blocker and chronic steroid use as outpatient medications. We further identified that being Caucasian, on an alpha-blocker, and having a higher temperature increased the odds of declining further to septic shock.

Phenotyping the subgroup of patients that present with sepsis and further decline to shock has been the focus of recent studies. Similar to our findings, the proportion of septic patients who developed shock between 4 and 48 h after admission was more than half in this recently published work \[[@R11]\]. The great majority of these patients developed shock within 24 h, and pneumonia was a common source of infection. Variables associated with progression to shock included female gender, coronary artery disease, bandemia and elevated lactate \[[@R11]\].

Our study similarly sought to identify risk factors for progression to septic shock and suggest mechanisms that may contribute to vascular decompensation in INT patients. It could be argued that the INT patients were at an earlier point of their sepsis trajectory, and became acutely hypotensive as their disease progressed during the early hospital course. This hypothesis is supported by the findings that INT patients have fewer positive cultures and fewer isolates of gram-positive organisms than IH patients. However, number of days of illness prior to presentation did not differ significantly between the two groups. Additionally, INT patients' APACHE II scores trended lower than those of the IH patients (P \< 0.07), and would have differed more had APACHE II scores been taken at presentation before INT patients became hypotensive, rather than at 24 h. Moreover, less severity of illness at presentation would suggest better outcomes in the INT subgroup compared to the IH subgroup, given prior studies showing that early treatment with fluid resuscitation and antibiotics improve survival \[[@R07], [@R08]\].

Fluid resuscitation could have contributed to the transition from a hemodynamically compensated circulation in the INT patients to a full-blown septic shock state. Fluid resuscitation is a mainstay of treatment for septic shock to maintain pressure in the central circulation \[[@R09]\]. However, it does not treat the main pathophysiology of distributive shock and, when given excessively, it could potentially compromise the microcirculation due to worsening interstitial edema \[[@R16], [@R17]\]. The fluid expansion as supportive therapy (FEAST) trial questioned the role of fluid resuscitation in sepsis, showing higher mortality in fluid-resuscitated African children with sepsis than in non-resuscitated controls \[[@R06]\]. The *post hoc* analysis, based on presenting symptoms and predominant terminal clinical events, showed that cardiovascular collapse was the major cause of death after rapid fluid resuscitation rather than fluid overload \[[@R18]\]. A possible explanation is that rapid restoration of circulatory volume via fluid resuscitation has unintended consequences, including the interruption of the compensatory, sympathetic, and innate response to hypovolemia \[[@R17], [@R19]\]. This compensatory response distinguished the INT patients from the IH patients. The INT patients presented in a relatively hyperadrenergic state, maintaining blood pressure along with higher heart rate and body temperature. In this scenario, fluid bolus given early in sepsis management results in the rapid conversion from vasoconstriction to vasodilation by disseminating a localized and contained focus of cytokines from infected tissue to the systemic circulation. In this regard, we observed significantly more instances of pneumonia in the INT subgroup compared to the IH subgroup. Among the 20 patients with pneumonia overall, 15 were in the INT subgroup. This observation supports the hypothesis that the transition from normotension to septic shock may involve fluid-driven dissemination of cytokines, or other cell derived mediators, from a localized site of infection with a rich vascular supply, like the pulmonary microcirculation, to the systemic circulation. Although the INT subgroup did receive more fluid volume than the initial septic shock subgroup during the first 24 h (4.3 L vs. 3.9 L), the difference did not reach statistical significance.

An alternative explanation for hypotension during treatment of early sepsis may be the presence of a Jarisch-Herxheimer reaction following the administration of antibiotics \[[@R20], [@R21]\]. Time to initiation of first antibiotics was similar in both groups. Interestingly, antibiotic administration occurred before the recognition of hypotension in the INT subgroup (2 h 52 m vs. 3 h 18 m). Also, the INT group had relatively more gram-negative isolates than the septic shock subgroup. These observations suggest that antibiotics could contribute to the onset of septic shock via a Jarisch-Herxheimer reaction by lysing bacteria with the subsequent release of endotoxin. This question warrants further study.

We found two other differences between the INT and IH subgroups that may have affected their hemodynamic state at presentation. Although the Charlson comorbidity index was the same for both subgroups, INT patients were taking alpha-blockers as outpatients significantly more frequently than IH patients. Chronic alpha-blocker therapy may result in peripheral adrenergic receptor up-regulation and contribute to hyper-adrenergic compensation. Therefore, patients taking alpha-blockers may be more susceptible to acute decompensation after interruption of their hyper-adrenergic, compensatory response, as may occur after fluid resuscitation. Also, INT patients were more frequently on chronic steroid therapy prior to presentation, another factor that may have affected their ability to sustain a compensated hemodynamic state.

Limitations of our study include its retrospective design. Observed variables that are associated with the INT presentation cannot be regarded as causal. Also, the Veterans Affairs medical center has predominantly male patients with a potentially greater fraction of patients on alpha-blocker therapy, possibly limiting the generalizability of our findings. Finally, both INT and IH groups had similar mortality at 28 days and 1 year, similar organ failures, and similar ICU and hospital lengths of stay for both patient subgroups.

In summary, we found that the two presentations of septic shock, INT and IH, occur with equal frequency. Patient-specific variables may discriminate between these presentations. Although INT patients seem to have less severity of illness based on hemodynamic stability at presentation, we found no differences in important clinical outcomes between the two subgroups. However, because the INT group provides a point of origin, or time zero, for progression into septic shock, further study of this group may provide clarification of the pathophysiology and mechanisms of septic shock.

Key messages {#s4a}
------------

In our population, 46% of patients who present with sepsis progress to septic shock.

Being Caucasian or on an alpha-blocker increased the odds of progressing to septic shock independently at least three-fold.

Each 1 °F increase above the mean of the cohort increased odds of progressing to shock 36%.

Timing of antibiotic initiation, amount of fluid resuscitation in first 24 h, vasopressor use, and mortality at 28 days did not increase odds of progression to shock.
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:   diabetes mellitus
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:   end-stage renal disease

EMR

:   electronic medical record

FEAST

:   fluid expansion as supportive therapy

IH

:   initial hypotension

INT

:   initial normotension

MAP

:   mean arterial pressure

SBP

:   systolic blood pressure
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